What are the outcomes for refractory epilepsy surgery?
The largest study to date shows the result depends on the histopathology
Most people undergoing surgery for drug-resistant focal epilepsy can expect to be free of disabling seizures two years afterwards, although outcomes depend on lesion histopathology, researchers report.
Surgery should, therefore, be considered in every person with such refractory epilepsy, with 50-77.5% of patients likely to benefit, they write in the Lancet Neurology.
